Amphetamine
Amphetamine | |
---|---|
Molecular structure via molpic | |
Molecular formula | C9H13N |
Molecular mass | 135.21 g/mol |
Density | 0.913 g/cm3 |
Appearance | Mobile liquid |
Odor | Amine odor |
Taste | Acrid, burning taste |
Melting point | 25 °C |
Boiling point | 392 to 397 °F at 760 mmHg (EPA, 1998) |
Decomposition | When heated to decomposition it emits toxic fumes of nitroxides. |
Solubility | Sulfate: Soluble in water Freebase: Soluble in ether, ethanol and chloroform |
Chirality | racemic |
Identifiers [] | |
---|---|
IUPAC name | 1-phenylpropan-2-amine |
Cannonical SMILES | CC(CC1=CC=CC=C1)N |
InChI | InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3 |
InChIKey | KWTSXDURSIMDCE-UHFFFAOYSA-N |
Dosing |
---|
Intravenous [] | |
---|---|
Threshold | 15 - 20 mg |
Light | 20 - 22 mg |
Common | 22 - 25 mg |
Strong | 25 - 30 mg |
Heavy | 30 mg |
Insufflated [] | |
---|---|
Threshold | 0.25 - 1 mg |
Light | 1 - 10 mg |
Common | 10 - 20 mg |
Strong | 20 - 30 mg |
Heavy | 30 - 40 mg |
Oral [] | |
---|---|
Threshold | 0.5 - 5 mg |
Light | 5 - 10 mg |
Common | 10 - 20 mg |
Strong | 20 - 30 mg |
Heavy | 30 - 60 mg |
Rectal [] | |
---|---|
Threshold | 5 mg |
Light | 5 - 6 mg |
Common | 6 - 7 mg |
Strong | 7 - 10 mg |
Heavy | 10 - 13 mg |
Statistically derived dosages by Sernyl |
Amphetamine (also known as Amfetamine, Desoxynorephedrine, Norephedrane, 1-Phenyl-2-aminopropane, Elastonon, Fenopromin, Phenedrine, alpha-Methylphenethylamine, beta-Aminopropylbenzene or Propisamine and brand names including Adderall and Evekeo) is a stimulant substance of the phenethylamine class.
History and culture
Amphetamine was first synthesized 1887 in Germany by Lazăr Edeleanu.
However, its effects remained unknown until 1927, when Gordon Alles discovered it to have stimulant properties.
Chemistry
Amphetamine is typically prepared in the form of its amine salts sulfate, hydrochloride, aspartate, adipate, tartrate, chlorphenoxyacetate and phosphate.
Amphetamine is a racemic mixture of two optical stereoisomers:
Pharmacology
Amphetamine acts as a monoamine releasing agent and monoamine reuptake inhibitor.
Enzyme activity
Amphetamine is a substrate of CYP2A6, coadministration of substances which inhibit CYP2A6 may result in altered drug effects and prolong its elimination half-life.
Subjective effects
Cognitive effects [] |
---|
Sensory effects [] |
---|
Legal status
- UN: Amphetamine is a Schedule II controlled substance under the "convention on psychotropic substances".
- Australia: Amphetamine is a Schedule 8 controlled substance under the "Poisons Standard".
- Brazil: Amphetamine is a Class A3 psychoactive substance.
- Canada: Amphetamine is a Schedule I drug under the "Controlled Drugs and Substances Act".
- Germany: Amphetamine is a Anlage III controlled substance. It can only be prescribed on a narcotic prescription form under the "Betaeubungsmittelgesetz".
- Japan: Amphetamine is a prohibited substance.
- Luxembourg: Amphetamine is a Schedule II controlled substance under the "convention on psychotropic substances".
- The Netherlands: Amphetamine is a List I controlled substance under the "Opiumwet".
- New Zealand: Amphetamine is a Class B controlled substance.
- Poland: Amphetamine is a Group II-P controlled substance.
- South Korea: Amphetamine is a Schedule II controlled substance under the "convention on psychotropic substances".
- Sweden: Amphetamine is a Schedule II controlled substance under the "convention on psychotropic substances".
- Switzerland: Amphetamine is a Verzeichnis A controlled substance. Medicinal use is permitted.
- Thailand: Amphetamine is a Category 1 narcotic under the "Thai Narcotic Act of 2012".
- United Kingdom: Amphetamine is a Class B drug under the "Misuse of Drugs Act 1971".
- United States: Amphetamine is a Schedule II controlled substance under the "convention on psychotropic substances".